In 2020, Walgreens Boots Alliance (Nasdaq: WBA) announced that it would be investing $1 billion in a relatively new primary care company: VillageMD.
Since that point, the home- and community-focused VillageMD has thrived in the partnership with the behemoth retailer, so much so that Walgreens invested another $5.2 billion in the company this October.
Despite a clear vision and aspirational goals upon VillageMD’s founding, the position the company is now in is not a place its co-founders – including Chief Growth Officer Paul Martino – could have previously pictured.
Martino joined Home Health Care News for a conversation detailing how he and two other co-founders took an idea and turned it into a company they believe could be “the largest at-risk primary care provider” in the country.
HHCN is pleased to share the recording and transcript of our HHCN+ TALKS conversation with Martino. Read on to learn more about:
— What Walgreens’ investment in VillageMD means for home-based care in the U.S.
— How and why VillageMD created a successful strategy that turned it from a startup to a household name
— How Martino pitched VillageMD to other companies along the way – and also found the right partners
— Where VillageMD sees itself and the rest of the health care industry going in the future
Sign up for HHCN + to read this exclusive content.
Need more than 5 members? Contact us for more information.
* per member
Already a member?
The post How VillageMD Went from Startup to One of Walgreens’ Most Important Partners appeared first on Home Health Care News.